Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-01-18 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FOUGERES (35300), Ille-et-Vilaine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE BONABRY : revenue, balance sheet and financial ratios
PHARMACIE DE BONABRY is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FOUGERES (35300),
this company of category PME
shows in 2023 a net income positive of 142 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE BONABRY (SIREN 817885007)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
142 061 €
196 951 €
199 093 €
128 083 €
149 922 €
139 455 €
151 539 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DE BONABRY generates positive net income of 142 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 152 k€ -> 142 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
142 061 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 151%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
151.356%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
37.192%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE BONABRY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
707.227
453.306
297.961
459.106
285.14
198.828
151.356
Financial autonomy
11.381
17.036
23.322
16.819
24.152
31.421
37.192
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
151.362023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of PHARMACIE DE BONABRY (151.36) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
37.19%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+11 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DE BONABRY (37.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 297.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
297.758
Liquidity indicators evolution PHARMACIE DE BONABRY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
205.841
249.324
216.04
250.16
280.501
286.771
297.758
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
297.762023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent
In 2023, the liquidity ratio of PHARMACIE DE BONABRY (297.76) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DE BONABRY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE BONABRY is estimated at
1 676 245 €
(range 1 019 405€ - 2 356 424€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1019k€1676k€2356k€
1 676 245 €Range: 1 019 405€ - 2 356 424€
NAF 5 année 2023
Valuation method used
Net Income Multiple
142 061 €
×
11.8x
=1 676 245 €
Range: 1 019 405€ - 2 356 425€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE BONABRY with other companies in the same sector:
Frequently asked questions about PHARMACIE DE BONABRY
What is the revenue of PHARMACIE DE BONABRY ?
The revenue of PHARMACIE DE BONABRY is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE BONABRY profitable?
Yes, PHARMACIE DE BONABRY generated a net profit of 142 k€ in 2023.
Where is the headquarters of PHARMACIE DE BONABRY ?
The headquarters of PHARMACIE DE BONABRY is located in FOUGERES (35300), in the department Ille-et-Vilaine.
Where to find the tax return of PHARMACIE DE BONABRY ?
The tax return of PHARMACIE DE BONABRY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE BONABRY operate?
PHARMACIE DE BONABRY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart